Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
HRP20120535T1 - Dihidroksi izopropil fenil morfolin ilmetil fenil izoksazol karboksilna kiselina etilamid mesilat njegovi hidrati i polimorfi te formulacije koje sadrže te oblike - Google Patents
[go: Go Back, main page]

HRP20120535T1 - Dihidroksi izopropil fenil morfolin ilmetil fenil izoksazol karboksilna kiselina etilamid mesilat njegovi hidrati i polimorfi te formulacije koje sadrže te oblike - Google Patents

Dihidroksi izopropil fenil morfolin ilmetil fenil izoksazol karboksilna kiselina etilamid mesilat njegovi hidrati i polimorfi te formulacije koje sadrže te oblike Download PDF

Info

Publication number
HRP20120535T1
HRP20120535T1 HRP20120535AT HRP20120535T HRP20120535T1 HR P20120535 T1 HRP20120535 T1 HR P20120535T1 HR P20120535A T HRP20120535A T HR P20120535AT HR P20120535 T HRP20120535 T HR P20120535T HR P20120535 T1 HRP20120535 T1 HR P20120535T1
Authority
HR
Croatia
Prior art keywords
phenyl
morpholin
ylmethyl
dihydroxy
carboxylic acid
Prior art date
Application number
HRP20120535AT
Other languages
English (en)
Croatian (hr)
Inventor
Martin@James@Drysdale
Brian@William@Dymock
Christoph@Krell
Michael@Mutz
Holger@Petersen
Weijia@Zheng
Original Assignee
Novartis@Ag
Vernalis@@R@D@@Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38134307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20120535(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis@Ag, Vernalis@@R@D@@Ltd filed Critical Novartis@Ag
Publication of HRP20120535T1 publication Critical patent/HRP20120535T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HRP20120535AT 2007-03-01 2008-02-28 Dihidroksi izopropil fenil morfolin ilmetil fenil izoksazol karboksilna kiselina etilamid mesilat njegovi hidrati i polimorfi te formulacije koje sadrže te oblike HRP20120535T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07103346 2007-03-01
PCT/EP2008/052443 WO2008104595A1 (en) 2007-03-01 2008-02-28 Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms

Publications (1)

Publication Number Publication Date
HRP20120535T1 true HRP20120535T1 (hr) 2012-07-31

Family

ID=38134307

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20120535AT HRP20120535T1 (hr) 2007-03-01 2008-02-28 Dihidroksi izopropil fenil morfolin ilmetil fenil izoksazol karboksilna kiselina etilamid mesilat njegovi hidrati i polimorfi te formulacije koje sadrže te oblike

Country Status (40)

Country Link
US (3) US8163747B2 (sr)
EP (2) EP2131845B1 (sr)
JP (1) JP2010520176A (sr)
KR (1) KR20090122218A (sr)
CN (2) CN101636162A (sr)
AR (1) AR065519A1 (sr)
AT (1) ATE552836T1 (sr)
AU (1) AU2008220800B2 (sr)
BR (1) BRPI0807992A2 (sr)
CA (1) CA2678043A1 (sr)
CL (1) CL2008000618A1 (sr)
CO (1) CO6210828A2 (sr)
CR (1) CR10989A (sr)
CY (1) CY1113805T1 (sr)
DK (1) DK2131845T3 (sr)
DO (1) DOP2009000209A (sr)
EA (1) EA017075B1 (sr)
EC (1) ECSP099602A (sr)
ES (1) ES2384906T3 (sr)
GE (1) GEP20115309B (sr)
GT (1) GT200900236A (sr)
HR (1) HRP20120535T1 (sr)
IL (1) IL200401A0 (sr)
MA (1) MA31204B1 (sr)
MX (1) MX2009009233A (sr)
NI (1) NI200900161A (sr)
NZ (1) NZ578854A (sr)
PA (1) PA8771101A1 (sr)
PE (1) PE20090166A1 (sr)
PL (1) PL2131845T3 (sr)
PT (1) PT2131845E (sr)
RS (1) RS52351B (sr)
SI (1) SI2131845T1 (sr)
SM (1) SMAP200900080A (sr)
TN (1) TN2009000357A1 (sr)
TW (1) TW200844102A (sr)
UA (1) UA101950C2 (sr)
UY (1) UY30943A1 (sr)
WO (1) WO2008104595A1 (sr)
ZA (1) ZA200905417B (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200922595A (en) * 2007-10-12 2009-06-01 Novartis Ag Organic compounds
TWI450898B (zh) * 2008-07-04 2014-09-01 Sigma Tau Res Switzerland Sa 具有抗腫瘤活性之芳基異唑化合物
JP5063815B2 (ja) * 2008-11-25 2012-10-31 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ 抗腫瘍および抗神経変性剤としての二環式ピラゾールおよびイソオキサゾール誘導体
PL2525796T3 (pl) * 2010-01-21 2016-09-30 Wodny roztwór zawierający 3 chinuklidynony do leczenia choroby hiperproliferacyjnej, autoimmunologicznej i serca
JP2013519727A (ja) * 2010-02-17 2013-05-30 イルドン ファーム シーオー．，エルティーディー． 新規の５員複素環誘導体及びその製造方法
KR20120031854A (ko) 2010-09-27 2012-04-04 한국전자통신연구원 시간 및 주파수 특징을 이용하는 음악 음원 분리 장치 및 방법
WO2013015661A2 (en) * 2011-07-28 2013-01-31 Ildong Pharm Co.,Ltd. Novel prodrugs of 5-(2,4-dihydroxy-5-isopropylphenyl)-n-ethyl-4-(5-methyl1-1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide
FR3039401B1 (fr) * 2015-07-31 2018-07-13 Les Laboratoires Servier Nouvelle association entre le 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione et un inhibiteur de la tyr kinase du egfr

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1611112T1 (sl) * 2003-02-11 2012-12-31 Vernalis (R&D) Limited Izoksazolne spojine kot inhibitorji vroäśinskih ĺ ok proteinov
US20060070405A1 (en) * 2004-10-06 2006-04-06 Anheuser-Busch, Inc. Method for the production of amber glass with reduced sulfur-containing emissions
US20100069458A1 (en) 2007-02-15 2010-03-18 Peter Wisdom Atadja Combination of lbh589 with other therapeutic agents for treating cancer
WO2010069458A1 (de) 2008-12-17 2010-06-24 Merck Patent Gmbh Hexahalochromat(lll)-komplexe

Also Published As

Publication number Publication date
ZA200905417B (en) 2010-05-26
UA101950C2 (ru) 2013-05-27
AU2008220800A1 (en) 2008-09-04
US8487095B2 (en) 2013-07-16
MA31204B1 (fr) 2010-02-01
DK2131845T3 (da) 2012-07-16
SI2131845T1 (sl) 2013-02-28
PL2131845T3 (pl) 2012-09-28
GEP20115309B (en) 2011-10-25
ECSP099602A (es) 2009-12-28
PA8771101A1 (es) 2009-02-09
CN102302500A (zh) 2012-01-04
EA200901141A1 (ru) 2010-04-30
EP2545921A3 (en) 2013-04-10
AR065519A1 (es) 2009-06-10
CO6210828A2 (es) 2010-10-20
PT2131845E (pt) 2012-07-10
EA017075B1 (ru) 2012-09-28
US20120172592A1 (en) 2012-07-05
IL200401A0 (en) 2010-04-29
SMAP200900080A (it) 2010-01-19
RS52351B (sr) 2012-12-31
ATE552836T1 (de) 2012-04-15
CL2008000618A1 (es) 2008-09-12
HK1139073A1 (en) 2010-09-10
AU2008220800B2 (en) 2012-02-16
US20100093732A1 (en) 2010-04-15
US20130296556A1 (en) 2013-11-07
KR20090122218A (ko) 2009-11-26
CA2678043A1 (en) 2008-09-04
GT200900236A (es) 2011-09-14
CN101636162A (zh) 2010-01-27
EP2545921A2 (en) 2013-01-16
DOP2009000209A (es) 2009-09-15
JP2010520176A (ja) 2010-06-10
BRPI0807992A2 (pt) 2014-06-17
US8163747B2 (en) 2012-04-24
EP2131845B1 (en) 2012-04-11
UY30943A1 (es) 2008-10-31
TW200844102A (en) 2008-11-16
ES2384906T3 (es) 2012-07-13
NI200900161A (es) 2010-07-27
CY1113805T1 (el) 2016-07-27
EP2131845A1 (en) 2009-12-16
NZ578854A (en) 2012-03-30
WO2008104595A1 (en) 2008-09-04
TN2009000357A1 (en) 2010-12-31
PE20090166A1 (es) 2009-03-14
MX2009009233A (es) 2010-06-02
CR10989A (es) 2010-03-01

Similar Documents

Publication Publication Date Title
HRP20120535T1 (hr) Dihidroksi izopropil fenil morfolin ilmetil fenil izoksazol karboksilna kiselina etilamid mesilat njegovi hidrati i polimorfi te formulacije koje sadrže te oblike
PE20061490A1 (es) Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1
JP2013505584A5 (sr)
PE20071185A1 (es) Derivados de fenilo como moduladores de ppar
PE20090609A1 (es) Compuestos de pirazol para controlar plagas de invertebrados
PE20081475A1 (es) Arilamidas sustituidas por tiazol u oxazol
RU2008139904A (ru) Фармацевтическая композиция для наружного применения
TW200635585A (en) Monocyclic substituted methanones
NZ592224A (en) Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
HRP20171572T1 (hr) Tripeptidi kao inhibitori epoksi keton proteaze
NO20080323L (no) Forbindelser og deres salter som er spesifikke overfor PPAR-reseptorer og EGF-reseptorer og deres anvendlse innen medisinen
EA200702670A1 (ru) Препарат тиенопиридинового ингибитора агрегации тромбоцитов
RU2005138590A (ru) Фармацевтически полезные соли производных карбоновой кислоты
AR124694A1 (es) Hidrato cristalino de sal de sodio de topramezona novedoso y método de preparación del mismo
RS52663B2 (sr) Nova kristalna forma tiotropijum bromida i proces njene pripreme
AR082870A1 (es) Derivados de tetrazoles y sus composiciones para su uso como funguicida o plaguicida
TW200833246A (en) Azolylmethyloxiranes, their use for controlling phytopathogenic fungi, and compositions comprising them
RU2017112971A (ru) Композиции для ухода за полостью рта, содержащие цинк, аргинин и серин
CY1109085T1 (el) Νεα αλατα
PE20120395A1 (es) Sal de potasio cristalina de analogos de lipoxina a4
RU2008151757A (ru) Пероральная композиция, содержащая 3-{5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-гидрокси-1, 2-бензизоксазол-6-ил)метокси]фенил}пропионовую кислоту или ее соль
MX2009006638A (es) Agente para erradicar helicobacter pylori que tiene actividad inhibidora sobre la secrecion de acido gastrico.
EA200601963A1 (ru) Соли дигидрожасмоновой кислоты и их применение в сельском хозяйстве
HRP20090134T3 (hr) Tripeptid i tetrapeptid sulfoni
ATE550314T1 (de) Verbessertes kristallines material